Have a personal or library account? Click to login
Advancements in the radiooncological treatment of high-risk prostate cancer: a quarter century of achievements Cover

Advancements in the radiooncological treatment of high-risk prostate cancer: a quarter century of achievements

Radiology and Oncology
Volume 56 (2022): Issue 3 (September 2022)
By: Matthias Moll,  Harald Herrmann,  Alexandru Zaharie and  Gregor Goldner  
Open Access
|Aug 2022

Authors

Matthias Moll

Matthias.moll@meduniwien.ac.at

Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Harald Herrmann

Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Alexandru Zaharie

Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Gregor Goldner

Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
DOI: https://doi.org/10.2478/raon-2022-0018 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 365 - 370
Submitted on: Feb 14, 2022
|
Accepted on: Mar 28, 2022
|
Published on: Aug 14, 2022
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
biochemical control,
gastrointestinal toxicity,
genitourinary toxicity,
dose escalation
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2022 Matthias Moll, Harald Herrmann, Alexandru Zaharie, Gregor Goldner, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 56 (2022): Issue 3 (September 2022)Next article